PGSP-Stanford Psy.D. Consortium, Palo Alto, California, USA.
Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Oncology. 2018;95(3):129-137. doi: 10.1159/000489266. Epub 2018 Jun 19.
Globally, tobacco use is a major modifiable risk factor and leading cause of many forms of cancer and cancer death. Tobacco use contributes to poorer prognosis in cancer care. This article reviews the current state of tobacco cessation treatment in oncology. Effective behavioral and pharmacological treatments exist for tobacco cessation, but are not being widely used in oncology treatment settings. Comprehensive tobacco treatment increases success with quitting smoking and can improve oncological and overall health outcomes. This article describes the components of a model treatment program, which includes automatic referrals for all current tobacco users and recent quitters, motivational interviewing during initial and follow-up contacts, combined behavioral and pharmacological interventions for cessation, and systematic follow-up phone calls for relapse prevention.
在全球范围内，烟草使用是一个主要的可改变的风险因素，也是许多癌症形式和癌症死亡的主要原因。烟草使用会导致癌症治疗的预后更差。本文综述了肿瘤学中烟草戒断治疗的现状。有效的行为和药物治疗方法可用于戒烟，但在肿瘤治疗环境中并未得到广泛应用。全面的烟草治疗可提高戒烟成功率，并改善肿瘤学和整体健康结果。本文描述了一个模型治疗方案的组成部分，该方案包括对所有当前烟草使用者和最近戒烟者进行自动转介、在初次和随访接触时进行动机性访谈、针对戒烟的联合行为和药物干预以及系统性的随访电话以预防复发。
